Clinical Trial Update: Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal [Phase 2]

View source ↗

Summary

Phase II trial evaluating concurrent intensity-modulated radiotherapy with Capecitabine, Mitomycin, and Panitumumab in stage II-IIIB anal canal squamous cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Canal Squamous Cell Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Mitomycin-C (mitomycin C)
• Panitumumab (panitumumab)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Carcinoma of Anal Canal | Phase 2 | Status: TERMINATED